These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6610125)

  • 41. Responses of children immunized with capsular polysaccharide of Hemophilus influenzae type b, by David H. Smith, MD, et al, Pediatrics, 1973;52:637-644; and Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100 000 vaccinees 3 months to 5 years of age in Finland, by Heikki Peltola, MD et al, Pediatrics, 1977;60:730-737.
    Peter CG
    Pediatrics; 1998 Jul; 102(1 Pt 2):252-4. PubMed ID: 9651448
    [No Abstract]   [Full Text] [Related]  

  • 42. Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota.
    Osterholm MT; Rambeck JH; White KE; Jacobs JL; Pierson LM; Neaton JD; Hedberg CW; MacDonald KL; Granoff DM
    JAMA; 1988 Sep; 260(10):1423-8. PubMed ID: 3261350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemophilus influenzae type b polysaccharide vaccines.
    Granoff DM; Cates KL
    J Pediatr; 1985 Sep; 107(3):330-6. PubMed ID: 3897497
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of pneumococcal vaccination against recurrent otitis media. Preliminary results of a field trial in Finland.
    Karma P; Luotonen J; Timonen M; Pöntynen S; Pukander J; Herva E; Grönroos P; Leinonen M; Sibakov M; Mäkelä PH
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):357-62. PubMed ID: 6778346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    Schneerson R; Robbins JB
    N Engl J Med; 1975 May; 292(21):1093-6. PubMed ID: 48191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pneumococcal vaccine and otitis media.
    Mäkelä PH; Sibakov M; Herva E; Henrichsen J; Luotonen J; Timonen M; Leinonen M; Koskela M; Pukander J; Pöntynen S; Grönroos P; Karma P
    Lancet; 1980 Sep; 2(8194):547-51. PubMed ID: 6106735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccine prevention of Haemophilus influenzae type b disease: past, present and future.
    Cochi SL; Broome CV
    Pediatr Infect Dis; 1986; 5(1):12-9. PubMed ID: 3511454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine.
    Käyhty H; Schneerson R; Sutton A
    J Infect Dis; 1983 Oct; 148(4):767. PubMed ID: 6605394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
    Ambrosino D; Schreiber JR; Daum RS; Siber GR
    Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can Hemophilus infections be prevented?
    Denny FW
    N Engl J Med; 1984 Jun; 310(24):1595-6. PubMed ID: 6610126
    [No Abstract]   [Full Text] [Related]  

  • 51. Failure of vaccination with Haemophilus influenzae vaccine.
    Pritikin R
    N Engl J Med; 1987 Jul; 317(2):115. PubMed ID: 3495734
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide.
    Hunter KW; Fischer GW; Hemming VG; Wilson SR; Hartzman RJ; Woody JN
    Lancet; 1982 Oct; 2(8302):798-9. PubMed ID: 6126667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fetal-neonatal passive immunization against Hemophilus influenzae, type b.
    Amstey MS; Insel R; Munoz J; Pichichero M
    Am J Obstet Gynecol; 1985 Nov; 153(6):607-11. PubMed ID: 3877464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The protective efficacy of Haemophilus b polysaccharide vaccine.
    Shapiro ED; Murphy TV; Wald ER; Brady CA
    JAMA; 1988 Sep; 260(10):1419-22. PubMed ID: 3261349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.
    Anderson P
    J Infect Dis; 1984 Jun; 149(6):1034-5. PubMed ID: 6610714
    [No Abstract]   [Full Text] [Related]  

  • 56. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
    Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
    J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
    [No Abstract]   [Full Text] [Related]  

  • 57. Hemophilus influenzae type B vaccine.
    N Engl J Med; 1985 Jan; 312(1):53-4. PubMed ID: 3871123
    [No Abstract]   [Full Text] [Related]  

  • 58. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.
    Käyhty H; Peltola H; Karanko V; Mäkelä PH
    J Infect Dis; 1983 Jun; 147(6):1100. PubMed ID: 6602191
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
    Käyhty H; Jousimies-Somer H; Peltola H; Mäketä PH
    J Infect Dis; 1981 Jan; 143(1):32-41. PubMed ID: 6783703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection from infection with Haemophilus influenzae type b by monoclonal antibody to the capsule.
    Gigliotti F; Insel RA
    J Infect Dis; 1982 Aug; 146(2):249-54. PubMed ID: 6980957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.